Viorica Magdalena Nagy

Summary

Publications

  1. ncbi request reprint Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy
    Viorica Magdalena Nagy
    Prof dr Ion Chiricuta Oncology Institute, Cluj Napoca, Romania
    Rom J Morphol Embryol 52:53-9. 2011
  2. pmc Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure
    Ovidiu Balacescu
    The Oncology Institute Prof Dr, Ion ChiricuŢă, 34 36 Republicii Street, 400015 Cluj Napoca, Romania
    BMC Cancer 14:246. 2014
  3. ncbi request reprint Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens
    V Nagy
    Department of Radiotherapy, Oncology Institute Ion Chiricuta, Cluj Napoca, Romania
    J BUON 12:389-94. 2007
  4. ncbi request reprint Updating the management of rectal cancer
    Viorica Magdalena Nagy
    Radiotherapy Department, Ion Chiricuta Oncology Institute, University of Medicine and Pharmacy Iuliu Hatieganu, Republicii Street, 34 36, 400015 Cluj Napoca, Romania
    J Gastrointestin Liver Dis 17:69-74. 2008
  5. ncbi request reprint Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial
    Viorica Nagy
    Department of Radiation Oncology, Ion Chiricuta Cancer Institute, Cluj Napoca, Romania
    Strahlenther Onkol 185:177-83. 2009
  6. ncbi request reprint Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up
    Viorica Magdalena Nagy
    Oncology Institute Prof Dr Ion Chiricuta, Cluj Napoca, Romania
    Int J Gynecol Cancer 22:1538-44. 2012
  7. ncbi request reprint Neoadjuvant conformal chemoradiation with induction chemotherapy for rectal adenocarcinoma. A prospective observational study
    Zsolt Fekete
    University of Medicine and Pharmacy Iuliu Haţieganu Institute of Oncology Prof Dr Ion Chiricuţa, Cluj Napoca, Romania
    J Gastrointestin Liver Dis 23:171-8. 2014

Collaborators

  • C Ordeanu
  • Piroska Virag
  • Zsolt Fekete
  • Ovidiu Balacescu
  • Nicolae Todor
  • Oana Tudoran
  • Stefan Hica
  • Sergiu Susman
  • Liliana Resiga
  • Rareş Buiga
  • Simona Visan
  • Laura Maja
  • Alina Simona Muntean
  • Csaba Csutak
  • Laura Pop
  • Bogdan Fetica
  • Loredana Balacescu
  • Meda Rus
  • Alin Rancea
  • Ioana Berindan-Neagoe

Detail Information

Publications7

  1. ncbi request reprint Expression of VEGF, VEGFR, EGFR, COX-2 and MVD in cervical carcinoma, in relation with the response to radio-chemotherapy
    Viorica Magdalena Nagy
    Prof dr Ion Chiricuta Oncology Institute, Cluj Napoca, Romania
    Rom J Morphol Embryol 52:53-9. 2011
    ..The aim of the present study was to determine the prognostic and/or predictive value of some biological markers of tumor angiogenesis and of their implication in increasing the efficacy of current treatments for this cancer...
  2. pmc Gene expression profiling reveals activation of the FA/BRCA pathway in advanced squamous cervical cancer with intrinsic resistance and therapy failure
    Ovidiu Balacescu
    The Oncology Institute Prof Dr, Ion ChiricuŢă, 34 36 Republicii Street, 400015 Cluj Napoca, Romania
    BMC Cancer 14:246. 2014
    ..In this study, we investigated the specific pathways and molecules responsible for baseline therapy failure in locally advanced squamous cervical cancer...
  3. ncbi request reprint Quality of life and treatment related toxicity in 335 patients with locally advanced cervical carcinoma treated by two chemoradiation regimens
    V Nagy
    Department of Radiotherapy, Oncology Institute Ion Chiricuta, Cluj Napoca, Romania
    J BUON 12:389-94. 2007
    ..This study compared 2 concomitant CT/RT regimens in terms of quality of life (QoL) and acute toxicity...
  4. ncbi request reprint Updating the management of rectal cancer
    Viorica Magdalena Nagy
    Radiotherapy Department, Ion Chiricuta Oncology Institute, University of Medicine and Pharmacy Iuliu Hatieganu, Republicii Street, 34 36, 400015 Cluj Napoca, Romania
    J Gastrointestin Liver Dis 17:69-74. 2008
    ..Recently, the novel 'targeted' therapies have been incorporated into a multidisciplinary approach for rectal cancer...
  5. ncbi request reprint Radiotherapy versus concurrent 5-day cisplatin and radiotherapy in locally advanced cervical carcinoma. Long-term results of a phase III randomized trial
    Viorica Nagy
    Department of Radiation Oncology, Ion Chiricuta Cancer Institute, Cluj Napoca, Romania
    Strahlenther Onkol 185:177-83. 2009
    ..To prove the superiority of concurrent radiochemotherapy (RTCT) over radiotherapy (RT) alone in locally advanced cervical carcinoma...
  6. ncbi request reprint Randomized phase 3 trial comparing 2 cisplatin dose schedules in 326 patients with locally advanced squamous cell cervical carcinoma: long-term follow-up
    Viorica Magdalena Nagy
    Oncology Institute Prof Dr Ion Chiricuta, Cluj Napoca, Romania
    Int J Gynecol Cancer 22:1538-44. 2012
    ..The evaluation of 5-year results obtained through 2 radiochemotherapy (RCT) regimens: cisplatin (CDDP), 20 mg/m × 5 days every 21 days; and CDDP, 40 mg/m per week in locally advanced cervical carcinoma...
  7. ncbi request reprint Neoadjuvant conformal chemoradiation with induction chemotherapy for rectal adenocarcinoma. A prospective observational study
    Zsolt Fekete
    University of Medicine and Pharmacy Iuliu Haţieganu Institute of Oncology Prof Dr Ion Chiricuţa, Cluj Napoca, Romania
    J Gastrointestin Liver Dis 23:171-8. 2014
    ....